Mark Davis on immunology research
Vaccinology has taken great leaps forward in the past decade, largely due to advanced analytical methods as well as a shift in researchers’ focus from rodents to humans.
Hints into long COVID
People with lower levels of an antiviral antibody as well as those with lung disease take longer to clear COVID-19 symptoms, say Stanford Medicine researchers.
Keto and Mediterranean good for diabetes
In a trial of the two low-carb diets, both were similarly effective in controlling blood glucose. Keto’s more severe carb restrictions did not provide additional overall health benefits.
‘Digital human’ helps reduce knee stress
A computer simulation that relates muscle activation patterns to harmful pressure on the knee helps participants adopt knee-protective strategies as they walk.
Pediatric emergency department recognized
Santa Clara County recognized Stanford’s pediatric emergency department for its ability to handle a broad spectrum of medical emergencies in young patients.
Targeting enzyme that fuels cancer cells
Stanford Medicine researchers have created a molecule that blocks an enzyme thought to be instrumental in causing colon cancer relapse or chemotherapy resistance.
Joseph Wu to be AHA president
Beginning July 2023, Wu will lead the nation’s largest nonprofit organization dedicated to advancing cardiovascular health.
Leaders pledge to address climate change
A roundtable at the White House on reducing the health care industry’s climate-warming emissions includes leaders from Stanford Medicine.
Awards for COVID-19 project, media work
A COVID-19 remembrance project, two videos, an article about bad brain cells and Stanford Medicine magazine have been recognized by the Council for Advancement and Support of Education.
Improving clinical trial diversity
The American Heart Association has provided funding to two Stanford Medicine professors to develop ways to diversify enrollment in heart disease clinical trials.